Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma
Frederick W. Thielen(University Medical Center Freiburg), Carin A. Uyl‐de Groot(Erasmus University Rotterdam), Renske M.T. ten Ham(Leidsche Rijn Julius Health Centers), Renaud Heine(Erasmus University Rotterdam), Sibren van den Berg(Dutch Cancer Society)
Cited by 26
Related Papers
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
|New England Journal of Medicine|2020|418
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation
|New England Journal of Medicine|2020|345
How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)
|Expert Review of Pharmacoeconomics & Outcomes Research|2016|138